Gut bacteria boost could help stop Cancer's return
NCT ID NCT07037004
First seen Oct 31, 2025 · Last updated Apr 09, 2026 · Updated 28 times
Summary
This study is testing if adding a specific probiotic (CBM588) to a standard immunotherapy drug (pembrolizumab) can better prevent kidney cancer from coming back after surgery. The trial will enroll 62 patients who have had surgery for high-risk kidney cancer. Researchers believe improving the balance of gut bacteria may help the patient's own immune system fight any remaining cancer cells more effectively.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE IV RENAL CELL CANCER AJCC V8 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
Contact Email: •••••@•••••
Contact
-
City of Hope at Irvine Lennar
Irvine, California, 92618, United States
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.